[HTML][HTML] Engineering interferons and interleukins for cancer immunotherapy
Cytokines are a class of potent immunoregulatory proteins that are secreted in response to
various stimuli and act locally to regulate many aspects of human physiology and disease …
various stimuli and act locally to regulate many aspects of human physiology and disease …
Immunological effects of conventional chemotherapy and targeted anticancer agents
The tremendous clinical success of checkpoint blockers illustrates the potential of
reestablishing latent immunosurveillance for cancer therapy. Although largely neglected in …
reestablishing latent immunosurveillance for cancer therapy. Although largely neglected in …
Combining antibody–drug conjugates and immune-mediated cancer therapy: what to expect?
HP Gerber, P Sapra, F Loganzo, C May - Biochemical pharmacology, 2016 - Elsevier
Blockade of immune-checkpoints has emerged as one of the most promising approaches to
improve the durability of anti-tumor responses in cancer patients. However, the fraction of …
improve the durability of anti-tumor responses in cancer patients. However, the fraction of …
The evolving role of immune checkpoint inhibitors in cancer treatment
GK Pennock, LQM Chow - The oncologist, 2015 - academic.oup.com
Traditional treatment modalities for advanced cancer (radiotherapy, chemotherapy, or
targeted agents) act directly on tumors to inhibit or destroy them. Along with surgery, these …
targeted agents) act directly on tumors to inhibit or destroy them. Along with surgery, these …
Increasing cure rates of solid tumors by immune checkpoint inhibitors
W Ma, R Xue, Z Zhu, H Farrukh, W Song, T Li… - … Hematology & Oncology, 2023 - Springer
Immunotherapy has become the central pillar of cancer therapy. Immune checkpoint
inhibitors (ICIs), a major category of tumor immunotherapy, reactivate preexisting anticancer …
inhibitors (ICIs), a major category of tumor immunotherapy, reactivate preexisting anticancer …
Anticancer cytokines: biology and clinical effects of interferon-α2, interleukin (IL)-2, IL-15, IL-21, and IL-12
T Floros, AA Tarhini - Seminars in oncology, 2015 - Elsevier
Efforts over nearly four decades have focused on ways to use cytokines to manipulate the
host immune response towards cancer cell recognition and eradication. Significant …
host immune response towards cancer cell recognition and eradication. Significant …